Please ensure Javascript is enabled for purposes of website accessibility


Dominique P. Bridon, Ph.D.

Dominique Bridon, Ph.D. currently acts as Executive Vice President, Chief Operating Officer for Optivia Biotechnology.

Dr. Bridon holds a doctorate in organic chemistry from the University of Paris XI and completed post-doctoral research at the University of California, Berkeley. He has an engineering degree in polymer chemistry from École Nationale Supérieure d’Ingénieur of Clermont-Ferrand.

Before joining Optivia, Dr. Bridon held the position of Senior Vice President of Research and Innovation at Ipsen, based in the Boston area. Dr. Bridon was responsible for the drug discovery, translational research and formulation teams in the US and in Europe, as well as all external research partnerships and collaborations.

Prior to Ipsen, from 1997 to 2006, Dr. Bridon served as Vice President of Research and Chief Technical Officer of ConjuChem, a company he co-founded in Montreal, Canada. He previously served as Director of Biological Chemistry for Redcell, Inc. in South San Francisco. From 1989 through 1996, Dr. Bridon held various scientific positions at Abbott Laboratories in the diagnostic and pharmaceutical research areas.

During his career, Dr. Bridon has served as a member on the Board of Directors and the Scientific Board of Directors for several start-up companies and as an advisor to several biotech companies and venture capital funds